Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
(-) Other news
Partner news
Press release

Period

2020
2019
2018

Jan
Mar
Apr
Jun
Jul
Aug
Sep
Oct
Dec

Locations & regions

EMEA

Focus area

Pharmaceuticals

Clear filters

News

23 September 2020

Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award

Read full story

17 September 2020

XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer

Read full story

Cyprio Wins Women Startup Challenge Europe HealthTech

Read full story

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

Read full story

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

Read full story

binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health

Read full story

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story

Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38

Read full story

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

Read full story

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Read full story

14 December 2018

Analytics 4 Life and Actelion to Develop New Diagnostics for Pulmonary Hypertension

Read full story

Sidebar

Currently trending

Currently trending

Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award
XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer
ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration
Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal
GI Windows Raises $16.4M in Series A-1 Financing
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases
ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Trending

Trending

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Johnson & Johnson Innovation, Change One Thing, Change Everything: Medopad

Johnson & Johnson Innovation, Change One Thing, Change Everything: Exonate